Perspectives on 2015 Drug and Treatment Approvals

被引:0
作者
Mohundro, Michael M. [1 ]
机构
[1] Our Lady Lake Reg Med Ctr, Pharm, Baton Rouge, LA USA
关键词
CARDIOVASCULAR EVENTS; REDUCING LIPIDS; HEART-FAILURE; NEPRILYSIN; INHIBITION; EFFICACY; SAFETY;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:5 / 8
页数:4
相关论文
共 21 条
[1]  
[Anonymous], 2015, PHARM APPROVALS 0317
[2]  
[Anonymous], 2015, SAV PRESCR INF
[3]  
[Anonymous], 2014, OPD PRESCR INF
[4]  
[Anonymous], 2015, FDA POSTP ADV COMM R
[5]  
[Anonymous], CHOLB CHOL AC
[6]  
[Anonymous], 2014, ONCLIVE 0129
[7]  
[Anonymous], COS SEC
[8]  
[Anonymous], 2015, NOV NEW DRUGS 2014 S
[9]  
[Anonymous], 2014, BIOL BIOS OV
[10]  
[Anonymous], 2015, POSTP ARTHR ADV COMM